Our research results confirmed that FDX1 overexpression promoted the expression of E-cadherin and inhibited the expression of N-cadherin, which suggested that FDX1 may suppress the EMT process in ccRCC. The gene discussed is CDH2; the disease is nonpapillary renal cell carcinoma.